Lifetime Citizen Portal Access — AI Briefings, Alerts & Unlimited Follows
BioNorth Texas and Federal Laboratory Consortium partner to speed federal lab tech transfer to industry
Loading...
Summary
BioNorth Texas has signed a memorandum of understanding with the Federal Laboratory Consortium for Technology Transfer (FLC) to help regional bioscience startups license federal lab research, access collaborative R&D opportunities, and accelerate commercialization; the groups also highlighted the IC3 summit in Dallas as a networking hub.
Kathleen Otto Rosenblum, chief executive officer of BioNorth Texas, said her organization has signed a memorandum of understanding with the Federal Laboratory Consortium for Technology Transfer (FLC) to help early-stage bioscience companies access federal laboratory research and move technologies to market.
"This partnership gives us unparalleled access to the federal lab research that can fuel bioscience growth," Rosenblum said, adding that the collaboration creates opportunities for licensing, collaborative R&D and joint ventures that can fast-track product development.
The agreement, Nelson noted, builds on the FLC's mission to connect federal researchers with industry. Andrea Nelson, host of the FLC's Transfer Files podcast, introduced the MOU during the episode and framed the partnership as a way to scale regional tech-transfer efforts.
Rosenblum described BioNorth Texas's practical role: connecting university spinouts and small startups to mentorship, investors and regulatory expertise, and staging events that create the "connective tissue" between scientists and entrepreneurs. She emphasized funding and regulatory navigation as the sector's largest barriers, saying early-stage companies often lack the teams and capital needed to progress through FDA and other approval processes.
As an example of facilitation work, Rosenblum recounted helping a Belgian university partner and a DFW Airport-certified logistics operation resolve paperwork and transport protocols for benign cell-transport testing, which she described as a small but essential piece of enabling international research collaboration.
Rosenblum also highlighted BioNorth Texas's IC3 summit—described as Innovation = capital × collaboration × commercialization—saying the event has grown from roughly 180 attendees to about 1,000 and will be held in September in Dallas at The Anatole. She said the partnership with the FLC will help bring federal lab resources and researchers into those kinds of industry-facing events.
On public perceptions, Rosenblum said improved connections between startups and federal researchers can help "shine the light" on government research and rebuild trust in federal science.
For entrepreneurs, Rosenblum advised building networks early, starting regulatory planning at the outset and engaging organizations such as BioNorth Texas to access mentorship, funding opportunities and commercialization pathways. She directed listeners to biontx.org for resources and recommended attending the IC3 summit for networking and industry engagement.
The FLC episode page and show notes at federallabs.org provide episode links and additional resources.

